MediciNova Inc.

02/01/2022 | Press release | Distributed by Public on 02/01/2022 05:35

MediciNova Receives a New Patent Covering MN-001 for the Treatment of Hypertriglyceridemia, Hypercholesterolemia, and Hyperlipoproteinemia in Korea